The Diagnosis Dilemma

To tell or not to tell?

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
In February 2007 Roz Zakheim learned she had non-Hodgkin’s lymphoma. The Los Angeles lawyer told her husband, her son, her friends, and her coworkers. But she didn’t tell her 91-year-old mother. “I’m the person primarily responsible for her,” Zakheim says. “I was just so worried about how devastating it would be to her.” 

Many cancer patients wrestle with the question, should I tell? And if so, whom to tell? Cancer experts believe most people join the candid cancer crowd.

“I told everybody right away,” says Hester Hill Schnipper, chief of oncology social work at Beth Israel Deaconness Medical Center in Boston, who has twice been diagnosed with breast cancer. “I’m one of those people who had trouble not telling the person in the checkout line at the grocery store.” She is a fan of disclosure: “I think it’s cathartic, a way of starting to own it. Every time you say it aloud, it’s a little more real.”

Then there are the selective tellers, like Zakheim. Some keep news of a cancer diagnosis from elderly or emotionally frail relatives. Others inform virtually no one—perhaps just a few members of their inner circle.

“When I was a young eager beaver social worker, I would have thought there was never a reason not to tell,” says Schnipper. Now she understands the impulse to cover up. “I’ve changed my opinion. Sometimes the right decision is not telling your 90-year-old mother in a nursing home in Florida.” Nonetheless, in cancer circles, honesty is usually regarded as the best policy. 

Cultural influences keep some people from sharing their diagnosis. Among Hindu religionists, cancer is often viewed as karmic payback for bad deeds from a past life, says Zul Surani, a community health educator who co-founded Saath, a nonprofit group that has a program to assist South Asian cancer patients. “One of our survivors said people in her religious community were telling others, ‘Stay away even from her shadow, because she’ll bring you bad luck,’ ” says Surani.

The Latino community, by contrast, has a tendency to get the whole family involved in supporting a cancer patient, says Amelie Ramirez, director of the Institute for Health Promotion Research at the University of Texas Health Science Center at San Antonio. But she also sees stoic Latinos who think they can handle it on their own.

A fatalistic streak about cancer seals many lips. “In the Chinese community, people still think, ‘There’s nothing I can do about cancer, I will die soon,’ ” says Evaon Wong-Kim, PhD, a professor of social work at California State University, East Bay. Such a patient may not want to burden children, or even a spouse, with a cancer diagnosis. Yet this is hardly a Chinese-only viewpoint, Wong-Kim is quick to point out. Such feelings can be found in virtually every community, from African-American to white Anglo-Saxon Protestant, particularly among older generations.

And in every community, cancer patients make decisions based on their own personality and the personalities of their family members and friends. Louise Scott, 47, of Little Rock, Arkansas, told lots of people about her diagnosis of colon cancer but didn’t bring certain out-of-town buddies into the loop for a few months.

“I had close friends who were all problem-solvers,” she says. “They would have been giving me advice.” That’s not what she wanted: “I needed to figure it out myself.”

Crises can bring out the best in people. If you don't clue someone in, you don't give them the occasion to rise to the occasion.

If the disease is in a watch-and-wait stage, not telling doesn’t require elaborate deceptions. Diagnosed with smoldering myeloma eight years ago, Susan goes in for regular blood tests to monitor her condition, considered a precursor of active disease. But she shows no symptoms. The 56-year-old New Yorker asked that her last name not be used because she has confided in her husband, a few close friends, and that’s it. Her mother, siblings, and grown children have no clue. “I feel like my children have enough pressure in their lives,” she says. “They’d be nicer to me if I tell them, but they’re treating me like regular, and that’s good. I don’t want them to feel sorry for me or to worry.”

Late-stage disease may also prompt a degree of silence. Robin Baird practically made a public announcement when she was diagnosed with breast cancer in 2001 at age 43. The cancer has since recurred as metastatic disease. “I’ve never hidden it but I’ve told fewer people,” she says, “mostly because I don’t like the reaction. When you’ve had cancer multiple times, people do start looking at you like you are going to die. And I’m still Robin. I’m not cancer.”

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Cure Connections
Related Articles
Buying Hope: Life After a Fertility-Threatening Diagnosis
It’s all about having a plan. Plans give hope. Plans inspire.
Where Are the Men? BRCA Mutations and Male Awareness
BRCA mutations can lead to prostate and other cancers, and men are as likely as women to inherit them. Yet male awareness is lagging.
A View From a Young Lung Cancer Survivor: Genomic Testing Provides Hope
To gain a patient’s perspective on the Genomics of Young Lung Cancer Study and the importance of genomic testing, we spoke with Corey Wood, a 23-year-old trial participant and lung cancer survivor.
Surgery or Radiation for Prostate Cancer: What Determines the Choice?
Whether to opt for surgery or radiation to treat localized prostate cancer depends mainly on the stage and grade of disease.
More Doctor Time, More Understanding
I wish my doctors knew more about the emotional aspects of cancer and were given more time with me.
Related Videos
Amanda L. Kong on Seeking a Second Opinion for Breast Cancer Care at a High Volume Hospital
Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Amanda L. Kong on Breast Cancer Care at High Volume Hospitals
This study sought to identify patterns of breast cancer care at high volume hospitals.
Jill Stopfer on the Limitations of Multigene Panel Testing
Jill Stopfer, from the University of Pennsylvania, provides an overview of some limitations of multigene panel testing.
Jill Stopfer on the Benefits of Multigene Panel Testing
Jill Stopfer, from the University of Pennsylvania, discusses the benefits of multigene panel testing.
Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.